Safety and Effectiveness Study of Imiquimod Creams in the Treatment of External Genital Warts
Public ClinicalTrials.gov record NCT00674739. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Randomized, Double-blind, Placebo-controlled, Multi-center, Efficacy and Safety Study of Imiquimod Creams in the Treatment of External Genital Warts
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine whether imiquimod creams are effective in treating external genital warts (EGW). The secondary objective of this study is to provide information on recurrence of EGW. Additionally the study will also look at any adverse events associated with the use of the creams. External genital and perianal warts are caused by the infection of human papillomavirus or HPV. HPV infection is a sexually transmitted disease (STD). External genital warts look like small flesh-colored, pink, or red growths on or around the external skin of sex organs or perianal area. The warts may look similar to the small parts of a cauliflower or they may be very tiny and difficult to see. They often appear in clusters of three or four, and may grow and spread rapidly. They usually are not painful, although they may cause mild pain, bleeding, and itching.
Study identification
- NCT ID
- NCT00674739
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 470 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 12 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- May 2008 (Type not available)
- Primary completion
- Jul 2009 (Actual)
- Completion
- Jul 2009 (Actual)
- Last update posted
- May 24, 2011
2008 – 2009
United States locations
- U.S. sites
- 30
- U.S. states
- 12
- U.S. cities
- 28
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| WILMAX Clinical Research | Mobile | Alabama | 36608 | — |
| Montgomery Women's Health Associates | Montgomery | Alabama | 36116 | — |
| Women's Health Research | Phoenix | Arizona | 85015 | — |
| Precision Trials | Phoenix | Arizona | 85032 | — |
| Premier Pharmaceutical Research | Tempe | Arizona | 85282 | — |
| Visions Clinical Research | Tucson | Arizona | 85712 | — |
| Edinger Medical Group Clinical Research Center | Fountain Valley | California | 92708 | — |
| East Bay Dermatology Medical Group | Fremont | California | 94538 | — |
| Coastal Medical Research Group | San Luis Obispo | California | 93405 | — |
| Torrance Clinical Research | Torrance | California | 90505 | — |
| Clinicos, LLC | Colorado Springs | Colorado | 80904 | — |
| Colorado Medical Research Center | Denver | Colorado | 80210 | — |
| Visions Clinical Research | Boynton Beach | Florida | 33437 | — |
| Segal Institute for Clinical Research | North Miami | Florida | 33161 | — |
| Miami Research Associates | South Miami | Florida | 33143 | — |
| Discovery Clinical Research | Sunrise | Florida | 33316 | — |
| Perimeter Institute for Clinical Research | Atlanta | Georgia | 30338 | — |
| Medical College of Georgia | Augusta | Georgia | 30912 | — |
| Atlanta North Gynecology | Roswell | Georgia | 30075 | — |
| Indiana University Infectious Disease Research Group | Indianapolis | Indiana | 46202 | — |
| Dermatology Practice | Ann Arbor | Michigan | 48103 | — |
| Alegent Health Clinic | Omaha | Nebraska | 68124 | — |
| Private Practice | Great Neck | New York | 11021 | — |
| Private Practice | Purchase | New York | 10577 | — |
| State University of NY Stony Brook | Stony Brook | New York | 11794 | — |
| Philadelphia Institute of Dermatology | Philadelphia | Pennsylvania | 19144 | — |
| Professional Quality Research, Women Partners in Health | Austin | Texas | 78705 | — |
| Professional Quality Research, The Urology Team | Austin | Texas | 78759 | — |
| University of Texas Southwestern Medical Center Dermatology Dept | Dallas | Texas | 75390 | — |
| Progressive Clinical Research | San Antonio | Texas | 78229 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00674739, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted May 24, 2011 · Synced Oct 21, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00674739 live on ClinicalTrials.gov.